4//SEC Filing
Douglas Earl Martin 4
Accession 0001737287-25-000009
CIK 0001737287other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 8:16 PM ET
Size
6.7 KB
Accession
0001737287-25-000009
Insider Transaction Report
Form 4
Douglas Earl Martin
SVP, General Counsel
Transactions
- Award
Stock Option (Right to buy)
2025-01-24+512,370→ 512,370 totalExercise: $1.94Exp: 2035-01-24→ Common Stock (512,370 underlying) - Award
Common Stock
2025-01-24+144,928→ 594,252 total
Footnotes (1)
- [F1]25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001362155
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 8:16 PM ET
- Size
- 6.7 KB